Wittmann G, Szabon J, Mohcsik P, Nouriel SS, Gereben B, Fekete C, et al
BPC-157 vs TB-500 at a Glance The table below summarizes the core research distinctions between the two peptides before diving into tissue-specific findings
Jastreboff AM, Kaplan LM, Fras JP, et al
FOXO4-DRI is a senolytic peptide that targets p53, a crucial tumor suppressor that prevents genomic mutations 34
Cytoprotective and Anti-Ulcer Activity As a cytoprotective mediator, BPC-157 demonstrates protective effects on the gastrointestinal mucosal barrier while simultaneously addressing lesions in the liver, brain, and cardiovascular tissue
Because SAM is also required for many other methylation reactions, including gene-expression regulation, high NNMT activity draws heavily on SAM and is associated in studies with reduced NAD, a coenzyme central to cellular energy production